Provista Diagnostics
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2001 Westside Pkwy Ste 240, Alpharetta, ...Phone Number
(470) 758-2777Website
www.provistadx.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Provista Diagnostics
Videssa Breast is the first blood test of its kind to detect the presence or absence of breast cancer in women with abnormal or difficult-to-interpret mammographic findings. When used in combination with imaging, Videssa Breast can improve diagnostic accuracy and provide greater confidence and clarity when clinical assessment is challenging. Videssa Breast offers clarity for healthcare providers who must navigate complex decisions in women who present with difficult-to-interpret findings. Find out why everyone is talking about Videssa Breast! Download the company's free eBook to learn more about an exciting new blood test that improves breast cancer detection. Utilizing advanced proteomics technology, Provista Diagnostics has developed Videssa Breast, a simple blood test that detects and analyzes multiple tumor protein biomarkers for improved breast cancer detection. Unlike other blood-based technologies, such as, circulating tumor cells and cell-free DNA, breast cancer tumor proteinsRead more
Provista Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Provista Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Provista Diagnostics
Product Launch: Get notified when Provista Diagnostics launches new products
Funding: Get notified immidiatlly once Provista Diagnostics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Provista Diagnostics is spiking on competitors!
Earning: See what the market has to say on Provista Diagnostics recently announced quarterly report
Provista Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Provista Diagnostics had a recent Job posting/layoffs
Check if Provista Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Provista Diagnostics
Compare insights from companies similar to Provista Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Provista Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Provista Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Provista Diagnostics.
Provista Diagnostics financials insights
Gather financial insights about Provista Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$7.5M
2013
Private Equity
$6M
2014
Series B
$6M
2015
Private Equity
$3.9M
Series A
$7.5M
2016
Private Equity
$5.1M
Private Equity
$2.6M
Provista Diagnostics Tech Stack
A closer look at the technologies used by Provista Diagnostics
Provista Diagnostics News & Media
Todos Medical Reports Second Quarter 2021 Financial Results
Company recorded positive earnings of $0.01 per share as financial condition improvedTodos Medical’s CLIA/CAP Lab Provista Enters Into Reference Lab Agreement with Meadowlands Diagnostics to Provide cPass Neutralizing Antibody Blood Testing for Quantifying and Monitoring Key COVID-19 Immunity Biomarkers
Agreement will enable Meadowlands Diagnostics to offer cPass testing for COVID-19 immunity monitoring to its growing customer base including two additional New Jersey School system contractsTodos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes
Todos preparing to relocate headquarters to USA Todos preparing to relocate headquarters to USAAscenda BioSciences Acquires Provista Diagnostics
Ascenda BioSciences LLC, an Alpharetta, Georgia based clinical testing and diagnostics company, acquired Provista Diagnostics, Inc., an Alpharetta, GA-based women’s early-stage cancer diagnostic company. The amount of the deal, completed with the financial sponsorship by private equity firm The Strategic Group, P.R., LLC, was not dislcosed. Provista Diagnostics creates, produces, and markets innovative solutions directed […] The post Ascenda BioSciences Acquires Provista Diagnostics appeared fir
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Provista Diagnostics
Sign Up For FreeTo access detailed company insights
Videssa Breast is the first blood test of its kind to detect the presence or absence of breast cancer in women with abnormal or difficult-to-interpret mammographic findings. When used in combination with imaging, Videssa Breast can improve diagnostic accuracy and provide greater confidence and clarity when clinical assessment is challenging. Videss... Read More
